Home Products Diabetes AGE Reader
Assessing Cardiovascular Risk
The AGE Reader is a medical device to estimate cardiovascular risk.
The AGE Reader non-invasively assesses the accumulation of advanced glycation endproducts (AGE’s) in the patient using fluorescence of ultraviolet light. Patients place their forearm on the device to obtain a non-invasive AGE reading in less than 30 seconds.
AGE Reader features & benefits:
Powered by its proprietary technologies, this revolutionary device is a novel tool to researchers and clinicians and its arrival marks the new horizon in AGEs' detection and risk assessment on cardiovascular diseases, diabetes and renal failure.
- Real time
AGE Reader technology:
The AGE Reader™ has a light source which illuminates the tissue of interest. This light will excite fluorescent moieties in the tissue which will emit light with another wavelength. In the used wavelength band the major contribution in fluorescence comes from fluorescent AGEs linked mostly to collagen, but also to other proteins and lipids. The emitted light is detected using a spectrometer
AGE Reader Helpdesk